Bypassing the Blood-Brain-Barrier

Kurve Therapeutics is at the forefront of a new era of central nervous system (CNS) disorder treatments.

We are an innovative specialty-drug and medical technology company focused on developing potential treatments for neurodegenerative diseases. We are working on our patented Controlled Particle Dispersion® intranasal drug delivery platform, a next-generation technology with the aim to reshape the way CNS diseases are treated.

Kurve Therapeutics is taking bold steps to be market-ready — we are preparing to engage with FDA in an End of Phase II meeting to discuss our Phase III program for Alzheimer’s disease.

Find out how you can be a part of our plan for creating impactful change for those suffering from CNS disorders.

Sign up to be the first to know when we go live

First Name

Last Name

Phone Number

Company

Title/Role

Are you an accredited investor?

Yes No

Are you a caregiver to someone with cognitive loss?

Yes No

Are you a healthcare professional?

Yes No

Are you a main street investor?

Yes No

What is this message regarding?

Message